Mulders PF - Search Results

1

Endoscopy in patients with diarrhea during treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors: Is the cause in the mucosa?

Boers-Sonderen MJ, Mulder SF, Nagtegaal ID, Derikx LA, Wanten GJ, Mulders PF, van der Graaf WT, Hoentjen F, van Herpen CM. Boers-Sonderen MJ, et al. Among authors: mulders pf. Acta Oncol. 2016;55(4):444-8. doi: 10.3109/0284186X.2015.1119883. Acta Oncol. 2016. PMID: 26959411 Free article.

2

The reverse side of the victory: flare up of symptoms after discontinuation of sunitinib or sorafenib in renal cell cancer patients. A report of three cases.

Desar IM, Mulder SF, Stillebroer AB, van Spronsen DJ, van der Graaf WT, Mulders PF, van Herpen CM. Desar IM, et al. Among authors: mulders pf. Acta Oncol. 2009;48(6):927-31. doi: 10.1080/02841860902974167. Acta Oncol. 2009. PMID: 19452305 No abstract available.

3

Vascular endothelial growth factor and mTOR pathways in renal cell carcinoma: differences and synergies of two targeted mechanisms.

Mulders P. Mulders P. BJU Int. 2009 Dec;104(11):1585-9. doi: 10.1111/j.1464-410X.2009.08987.x. BJU Int. 2009. PMID: 20053190 Review.

4

Effect of tyrosine kinase inhibitor treatment of renal cell carcinoma on the accumulation of carbonic anhydrase IX-specific chimeric monoclonal antibody cG250.

Oosterwijk-Wakka JC, Kats-Ugurlu G, Leenders WP, Kiemeney LA, Old LJ, Mulders PF, Oosterwijk E. Oosterwijk-Wakka JC, et al. Among authors: mulders pf. BJU Int. 2011 Jan;107(1):118-25. doi: 10.1111/j.1464-410X.2010.09314.x. BJU Int. 2011. PMID: 20346054

5

Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients.

Desar IM, Jacobs JH, Hulsbergen-vandeKaa CA, Oyen WJ, Mulders PF, van der Graaf WT, Adema GJ, van Herpen CM, de Vries IJ. Desar IM, et al. Among authors: mulders pf. Int J Cancer. 2011 Jul 15;129(2):507-12. doi: 10.1002/ijc.25674. Epub 2010 Nov 12. Int J Cancer. 2011. PMID: 20839259

6

111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenib.

Desar IM, Stillebroer AB, Oosterwijk E, Leenders WP, van Herpen CM, van der Graaf WT, Boerman OC, Mulders PF, Oyen WJ. Desar IM, et al. Among authors: mulders pf. J Nucl Med. 2010 Nov;51(11):1707-15. doi: 10.2967/jnumed.110.078030. Epub 2010 Oct 18. J Nucl Med. 2010. PMID: 20956472 Free article.

7

Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccination.

Mulder SF, Jacobs JF, Olde Nordkamp MA, Galama JM, Desar IM, Torensma R, Teerenstra S, Mulders PF, Vissers KC, Punt CJ, de Vries IJ, van Herpen CM. Mulder SF, et al. Among authors: mulders pf. Clin Cancer Res. 2011 Jul 1;17(13):4541-9. doi: 10.1158/1078-0432.CCR-11-0253. Epub 2011 Jun 28. Clin Cancer Res. 2011. PMID: 21712444 Free article. Clinical Trial.

8

Better effect of sorafenib on the rhabdoid component of a clear cell renal cell carcinoma owing to its higher level of vascular endothelial growth factor-A production.

Kats-Ugurlu G, Maass C, van Herpen C, de Waal R, Oosterwijk E, Mulders P, Hulsbergen-van de Kaa C, Leenders W. Kats-Ugurlu G, et al. Histopathology. 2011 Sep;59(3):562-4. doi: 10.1111/j.1365-2559.2011.03923.x. Histopathology. 2011. PMID: 22034894 No abstract available.

9

Functional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot study.

Desar IM, ter Voert EG, Hambrock T, van Asten JJ, van Spronsen DJ, Mulders PF, Heerschap A, van der Graaf WT, van Laarhoven HW, van Herpen CM. Desar IM, et al. Among authors: mulders pf. Cancer Imaging. 2012 Jan 12;11(1):259-65. doi: 10.1102/1470-7330.2011.0032. Cancer Imaging. 2012. PMID: 22245974 Free PMC article.

10

Cediranib monotherapy in patients with advanced renal cell carcinoma: results of a randomised phase II study.

Mulders P, Hawkins R, Nathan P, de Jong I, Osanto S, Porfiri E, Protheroe A, van Herpen CM, Mookerjee B, Pike L, Jürgensmeier JM, Gore ME. Mulders P, et al. Eur J Cancer. 2012 Mar;48(4):527-37. doi: 10.1016/j.ejca.2011.12.022. Epub 2012 Jan 28. Eur J Cancer. 2012. PMID: 22285180 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters